1. P Ferenci, B Dragosics, H Dittrich et al., “Randomized Controlled Trial of Silymarin Treatment in Patients with Cirrhosis of the Liver,” Journal of Hepatology,vol. 9, no. 1 (July 1989: 105-13.
2. HP Ammon et al., “Pharmacology of Curcuma longa,” Planta Medica,vol. 57, no. 1 (February 1991): 1-7.
3. RB Arora et al., “Anti-inflammatory Studies on Curcuma longa,” Indian Journal of Medical Research,vol. 59 (1971): 1289.
4. DL Lamm, DR Riggs, “The Potential Application of Allium sativum (Garlic) for the Treatment of Bladder Cancer,” Urology Clinics of North America,vol. 27, no. 1 (February 2000): 157-62. M Thomson, M Ali, “Garlic [Allium sativum]: a Review of Its Potential Use as an Anti-Cancer Agent,” Current Cancer Drug Targets,vol. 3, no. 1 (February 2003): 67-81. E Dorant et al., “Garlic and Its Significance for the Prevention of Cancer in Humans: A Critical View,” British Journal of Cancer,vol. (1993): 424-29.
5. MS Hanafy et al., “Effect of Garlic on Lead Contents in Chicken Tissues,” DTW Dtsch Tierarztl Wochenschr,vol. 101, no. 4 (April 1994): 157-58.
6. G Shiota et al., “Rapid Induction of Hepatocyte Growth Factor mRNA after Administration of Gomisin A, a Lignan Component of Shizandra Fruits,” Res Commun Mol Pathol Pharmacol,vol. 94, no. 2 (November 1996): 141-46. Y Ohtaki Y et al., “Deoxycholic Acid as an Endogenous Risk Factor for Hepatocarcinogenesis and Effects of Gomisin A, a Lignan Component of Schizandra Fruits,” Anticancer Research,vol. 16, no. 2 (March 1996): 751-55.
7. R Chander et al., “Effect of Picroliv on Glutathione Metabolism in Liver and Brain of Mastomys natalensis Infected with Plasmodium berghei,” Indian Journal of Experimental Biology,vol. 30, no. 8 (August 1992): 711-14.
8. H Sherry Chow et al., “Modulatoin of Human Glutathione S-Transferences by Polyphenon E Intervention,” Cancer Epidemiology Biomarkers and Prevention, DOI 10:1158/1055-9965 EPI-06-0830.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.